Objective Anxiety and depression are prevalent mental health problems in people who use
illicit stimulants. Improved understanding of the temporal relationship between …

Objectives To examine the safety of an agonist-type treatment, lisdexamfetamine (LDX), at
250 mg/day among adults with methamphetamine (MA) dependence. Design A dose …

Methamphetamine (METH) is an illicit psychostimulant that is known to account for
substance abuse disorders globally, second only to opioids, yet has no approved …

Methamphetamine (METH) abuse exerts severe harmful effects in multiple organs,
especially the brain, and can induce cognitive dysfunction and memory deficits in humans …

The global rise in methamphetamine use and its negative effects warrants the need for
research exploring harm reduction and treatment interventions for individuals with …

Introduction A sustained-release tablet composed of a combination of the dopamine and
norepinephrine reuptake inhibitor bupropion (BUP) and the µ-opioid receptor antagonist …

Introduction Rising use of methamphetamine is causing significant public health concern in
Canada. The biological and behavioural effects of methamphetamine range from …

Background Worldwide methamphetamine (METH) use has increased significantly over the
last 10 years, and in the US, METH dependence has sky-rocketed among individuals with …

Australia has one of the highest rates in the world of the use of the crystalline form of
methamphetamine, a highly addictive stimulant that is often associated with a chronic …

Introduction This study aimed to gather a range of opinions, including those of affected
people (consumers, concerned others) to identify clinical research priorities for …